Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1

Journal of Trauma - Injury, Infection and Critical Care

Volumn 68, Issue 6, 2010, Pages 1328-1332

  Raoof, Mustafa ^a   Zhang, Qin ^a   Itagaki, Kiyoshi ^a   Hauser, Carl J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Inflammation; Neutrophils; SIRS; Trauma

Indexed keywords

CALCIUM; FORMYLPEPTIDE RECEPTOR LIKE 1; MITOCHONDRIAL PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CHEMOTAXIS; LEUKOCYTE ACTIVATION; LIVER CELL; MITOCHONDRION; NONHUMAN; PHAGOCYTE; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY BURST; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANALYSIS OF VARIANCE; ANIMALS; CALCIUM; CHEMOTAXIS, LEUKOCYTE; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MALE; MITOCHONDRIAL PROTEINS; NEUTROPHILS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, FORMYL PEPTIDE; RESPIRATORY BURST; SPECTROMETRY, FLUORESCENCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 77953788926     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181dcd28d     Document Type: Article

References (21)

1. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101: 1644-1655.
2. Cohen IL. Definitions for sepsis and organ failure. The ACCP/SCCM Consensus Conference Committee Report. Chest. 1993;103:656.
3. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med. 2000;26 (suppl 1):S64-S74.
4. Qiu H, Du B, Liu D. [Clinical study of systemic inflammatory response syndrome and multiple organ dysfunction syndrome in critically patients]. Zhonghua Wai Ke Za Zhi. 1997;35:402-405.
5. Ferrara JL. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol. 1993;5:794-799.
6. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2002;9:401-410.
7. Fisher CJ Jr, Dhainaut JF, Opal SM, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA. 1994; 271:1836-1843.
8. Abraham E, Anzueto A, Gutierrez G, et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet. 1998;351:929-933.
9. Marcker K. The formation of N-formyl-methionyl-sRNA. J Mol Biol. 1965;14:63-70.
10. Marcker K, Sanger F. N-formyl-methionyl-sRNA. J Mol Biol. 1964;8: 835-840.
11. Selvatici R, Falzarano S, Mollica A, Spisani S. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur J Pharmacol. 2006;534:1-11.
12. Taanman JW. The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta. 1999;1410:103-123.
13. Bianchetti R, Lucchini G, Crosti P, Tortora P. Dependence of mitochondrial protein synthesis initiation on formylation of the initiator methionyl-tRNAf. J Biol Chem. 1977;252:2519-2523.
14. Hauser CJ, Fekete Z, Adams JM, Garced M, Livingston DH, Deitch EA. PAF-mediated Ca2 influx in human neutrophils occurs via storeoperated mechanisms. J Leukoc Biol. 2001;69:63-68.
15. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2- indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
16. Tarlowe MH, Kannan KB, Itagaki K, Adams JM, Livingston DH, Hauser CJ. Inflammatory chemoreceptor cross-talk suppresses leukotriene B4 receptor 1-mediated neutrophil calcium mobilization and chemotaxis after trauma. J Immunol. 2003;171:2066-2073.
17. Wenzel-Seifert K, Seifert R. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L- phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E. J Immunol. 1993;150:4591-4599.
18. Malone DL, Kuhls D, Napolitano LM, McCarter R, Scalea T. Back to basics: validation of the admission systemic inflammatory response syndrome score in predicting outcome in trauma. J Trauma. 2001;51: 458-463. (Pubitemid 33009628)
19. Schiffmann E, Corcoran BA, Wahl SM. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci USA. 1975;72: 1059-1062.
20. Nadtochii SM, Bohuslavs'kyi A, Sahach VF. [Determination of the stable mitochondrial factor in vivo]. Fiziol Zh. 2003;49:25-30.
21. Tschaikowsky K, Sittl R, Braun GG, Hering W, Rügheimer E. Increased fMet-Leu-Phe receptor expression and altered superoxide production of neutrophil granulocytes in septic and posttraumatic patients. Clin Investig. 1993;72:18-25.